
Takeda Pharmaceutical (TAK) Stock Forecast & Price Target
Takeda Pharmaceutical (TAK) Analyst Ratings
Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%
Takeda Pharmaceutical (TAK) has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Takeda Pharmaceutical and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Takeda Pharmaceutical and is not a guaranteed prediction by Public.com or investment advice.
Takeda Pharmaceutical (TAK) Analyst Forecast & Price Prediction
Get the latest Takeda Pharmaceutical (TAK) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Takeda Pharmaceutical (TAK)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Takeda Pharmaceutical (TAK) Forecast
Analysts have given Takeda Pharmaceutical (TAK) a Buy based on their latest research and market trends.
According to 4 analysts, Takeda Pharmaceutical (TAK) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $23.50, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $23.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.